Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Flow Cytometry
Ultima Genomics Sequencing Platform Selected for 80,000-Sample UK Biobank Study
The project will analyze immune cells from blood samples to help researchers understand how differences in the immune system influence disease risk, progression, and treatment response. Ultima Genomics announced that its UG200 Sequencing Platform has been selected to power a new large-scale immune profiling study in collaboration with IMU Biosciences and UK Biobank.
Blood Test Differentiates Bacterial and Viral Infections in Febrile Infants
A ratio of neutrophil CD64 and monocyte CD169 expression demonstrated 100% sensitivity and 96.6% specificity for distinguishing bacterial from viral infections in an initial study of 60 infants. A blood test comparing the expression of two leukocyte surface markers can accurately differentiate between bacterial and viral infections in febrile infants under three months of age, according to preliminary findings presented at the European Emergency Medicine Congress in Paris.
Hematogenix MRD Assay Supports FDA Approval of Multiple Myeloma Therapy
The next-generation flow cytometry assay measured MRD-negative complete response, the primary efficacy endpoint supporting the accelerated approval of ZENBEXUS. Hematogenix announced that its proprietary next generation flow cytometry assay for multiple myeloma minimal residual disease (MRD) served as the analytical method for the pivotal efficacy endpoint supporting the Food and Drug Administration (FDA) accelerated approval of Bristol Myers Squibb’s ZENBEXUS (iberdomide).
GATA3-positivity and T follicular helper phenotype in transformed mycosis fungoides with leukemic involvement and prominent folliculotropism: a case report
Abstract Mycosis fungoides (MF) shows a broad clinical spectrum, ranging from indolent disease to aggressive variants with poor outcomes. T Follicular Helper (TFH) marker expression has been reported in a subset of MF, with uncertain prognostic significance, while GATA3 has emerged as a potential adverse prognostic marker in MF and nodal T-cell lymphomas.
ARUP Laboratories Launches Spectral Flow Cytometry Test for Multiple Myeloma Monitoring
The assay is designed to detect minimal residual disease with greater sensitivity than conventional flow cytometry. ARUP Laboratories announced the launch of ARUP Clarispect Multiple Myeloma MRD by Spectral Flow Cytometry, an assay designed to characterize small neoplastic populations with higher sensitivity than conventional flow cytometry. The test provides minimal residual disease (MRD) profiling for patients with multiple myeloma, according to a press release from ARUP Laboratories.
Single-Cell Sequencing May Identify New Exercise Biomarkers
Research suggests new sequencing technologies can help labs move from tissue-level averages to cell-specific testing for precision exercise medicine. Researchers from the Shanghai Jiao Tong University Journal Center are proposing a new roadmap for exercise medicine that uses single-cell sequencing to identify cell-type-specific biomarkers.
Non-classical immune checkpoint CD137/CD137L and CD200/CD200R expressions are regulated by the tumor immune microenvironment in lymph node aspirates from lung cancer patients
Abstract Background: Immune escape is a hallmark of lung cancer, and limited responsiveness to PD-1/PD-L1 blockade highlights the need to identify additional immunoregulatory mechanisms in the mediastinal tumor microenvironment (TME). Non-classical immune checkpoints, including CD137/CD137L and CD200/CD200R, may interact with classical pathways but remain insufficiently defined in metastatic lymph nodes (LNs).
Flow Cytometry in Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component, By Technology, By Indication, By Application, By End User, By Region & Competition, 2021-2031F
The global flow cytometry market within oncology is projected to expand significantly, increasing from USD 2.41 Billion in 2025 to USD 3.97 Billion by 2031, demonstrating an 8.67% Compound Annual Growth Rate. This technology, which uses laser-based methods to examine cellular characteristics in a fluid suspension, is vital for applications such as immunophenotyping, cell sorting, and detecting minimal residual disease, especially in the context of leukemia and lymphoma diagnostics.
HLA‐DR‐positive acute promyelocytic leukemia: A diagnostic pitfall in flow cytometry evaluation
A 62-year-old female presented with a 1-week history of generalized weakness, easy fatigability, reduced appetite, and bluish discoloration over the abdomen and limbs. There was a history of gum bleeding while brushing and two prior episodes of nasal bleeding 1 month earlier, both of which resolved spontaneously. No history of joint pains, rash, photosensitivity, or oral ulcers was noted. She denied fever, cough, dyspnea, hematuria, hematemesis, melena, or other bleeding manifestations.
HMGB1 regulates mitochondrial structure and reactive oxygen species balance during the transition from naïve to primed pluripotency
ORIGINAL RESEARCH article Volume 14 - 2026 | doi: 10.3389/fcell.2026.1807454 Reviewed by ORIGINAL RESEARCH article TY Tatiana Yu Starkova 1 SV Sergey V. Ponomartsev 1 NR Nariman R. Battulin 2 EI Evgeny I. Bakhmet 1 AA Andrey A. Kuzmin 1 SA Sergey A. Sinenko 1 AN Alexey N. Tomilin 1 1. Laboratory of Molecular Biology of Stem Cells, Institute of Cytology, Russian Academy of Sciences (RAS), Saint Petersburg, Russia 2.
Flow Cytometry Blood Test for Myeloma MRD Detection Launches
The test offers sensitivity comparable to next-generation sequencing methods while using noninvasive blood specimens instead of bone marrow aspirates. Quest Diagnostics has launched a blood test that uses flow cytometry methods to assess measurable residual disease (MRD) in patients with multiple myeloma. The Quest Flow Cytometry MRD for Myeloma test provides sensitivity comparable to next-generation sequencing methods while offering improved accessibility and cost-effectiveness.
Redefining the Health Risk of Battery Materials Through a Biologically Transformed Metal Mixture
1 Introduction The global transition to electric vehicles, a cornerstone of a sustainable future, is driven by a fundamental paradox: its core technology, the lithium-ion battery, may harbor an unrecognized threat to human health [1, 2]. At the heart of this revolution lies the nickel-manganese-cobalt (NCM) cathode, a heterometallic material that now dominates over 64 % of the electric vehicle market [3, 4].
Downregulation of CD19 Expression Associates With Mantle Cell Lymphoma Relapse Following CAR‐T Cell Therapy
Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request. Peer Review The peer review history for this article is available at https://publons.com/publon/10.1002/eji.70123. Supporting Information Filename Description eji70123-sup-0001-SuppMat.pdf269.8 KB Supporting File: eji70123-sup-0001-SuppMat.pdf.
Research Antibodies and Reagents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technology, By Application, By End User, By Region and Competition, 2020-2030F
The Global Research Antibodies and Reagents Market, valued at USD 10.69 Billion in 2024, is projected to experience a CAGR of 5.96% to reach USD 15.13 Billion by 2030.
Lupeol‐Loaded Liposomes: Triple‐Negative Breast Cancer (TNBC) Cytotoxicity and In Vivo Toxicological Evaluation
1 Introduction Drug discovery processes date back to the ancient ages when different sources of inorganic and organic compounds were extensively used to treat a wide variety of diseases. In modern times, following a scientific approach that started around the late 1800s, natural products have played a relevant role as inspiring sources for synthesizing bioactive compounds such as polysaccharides, alkaloids, and peptides [1-3].
Flow Cytometry In Oncology And Immunology Market Research 2025 - Global Industry Size, Share, Trends, Opportunity, And Forecast, 2020-2030F
Flow Cytometry In Oncology And Immunology Market Research 2025 - Global Industry Size, Share, Trends, Opportunity, And Forecast, 2020-2030F 2025-06-05 04:17:58 (MENAFN- GlobeNewsWire - Nasdaq) Opportunities in the Flow Cytometry in Oncology and Immunology Market include increasing global demand for precision diagnostics driven by cancer incidence and the rise of immuno-oncology.
Diagnosis and Classification of Primary Nodal Lymphomas in Dogs: A Consensus of the Oncology‐Pathology Working Group
1 Introduction Naturally-occurring lymphomas in domestic dogs represent a heterogeneous family of cancers with distinct pathological and clinical features. The clinical classification of lymphomas is conventionally based upon the organ site(s) at which they are most apparent, otherwise known as the cancer's anatomic form. The most common of these is the so-called “multicentric” form, in which the disease burden is most apparent in peripheral lymph nodes.
Sensitive Monitoring Of CAR+ T Cells In Peripheral Blood By Flow Cytometry And Real-Time qPCR
By Stefanie Biedermann, Laura Pluisch, Inga Herfort, Ardeshir Ansari, Elisabeth Pötschke, Iris Bürger, Christian Dose, and Christiane Siewert Autologous T cells, which are genetically modified to express a second-generation chimeric antigen receptor (CAR), are currently being investigated as a treatment for various human hematopoietic and other malignancies.
Advancements In High-Speed Cell Imaging And Spectral Detection Technologies In Histology And Cytology: Key Trend in The Histology And Cytology Global Market 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! What Are The Latest Market Size Figures And Growth Trends For The Histology And Cytology Market? In recent times, there has been swift expansion in the market size of histology and cytology. The market, which was valued at $17.12 billion in 2024, is projected to escalate to $19.26 billion in 2025 with a compound annual growth rate (CAGR) of 12.5%.
Complement C4 Antibody Market By Size, Share & Forecast 2030F
Forecast Period 2026-2030 Market Size (2024) USD 22.01 Billion Market Size (2030) USD 43.83 Billion CAGR (2025-2030) 12.14% Fastest Growing Segment Flow Cytometry Largest Market North America Market Overview Global Complement C4 Antibody Market was valued at USD 22.01 Billion in 2024 and is expected to reach USD 43.83 Billion in the forecast period with a CAGR of 12.14% through 2030.
Bioprocess Technology Market Set to Observe Robust Expansion at 16.2% CAGR, Projected to Reach $52.94 Billion By 2029 As Discussed In New Market Research Report
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! The Business Research Company (TBRC) announces its latest report on the Bioprocess Technology Market, focusing on the market's substantial growth potential, current developments and future trends. This comprehensive report highlights the potential of bioprocess technology in transforming biopharmaceutical production, sustainable practices and pandemic preparedness.
Central Lab Global Market Report 2025
A central lab is a facility that offers comprehensive services, consolidating all samples from various clinical locations involved in a trial. This centralized approach ensures uniformity in results and analyses. The primary services provided by central labs encompass genetic services, biomarker services, microbiology services, anatomic pathology and histology, specimen management and storage, special chemistry services, among others.
l‐Securinine Induces ROS‐Dependent Apoptosis on Pancreatic Cancer Cells via the PI3K/AKT/mTOR Signaling Pathway
Conflicts of Interest The authors declare no conflicts of interest. Supporting Information Filename Description jbt70036-sup-0001-Supplementary_table_1.docx17.4 KB Supporting information. jbt70036-sup-0002-Supplementary_table_2.docx14.3 KB Supporting information. jbt70036-sup-0003-Supplementary_table_3.docx25.5 KB Supporting information. jbt70036-sup-0004-Supplementary_table_4.docx21.9 KB Supporting information.
New Panel-Agnostic Automated AML Diagnosis Solution Unveiled
Summary: AHEAD Medicine introduced a new AI-powered diagnostic classification module to its Cyto-Copilot platform, enhancing AML versus non-neoplastic classification across multiple flow cytometry panels and instruments. Takeaways: The updated Cyto-Copilot module supports AML diagnostic classification across five flow cytometry test panels and instrument models. The AI-driven platform reduces diagnostic inconsistencies and workload by automating batch analysis of complex flow cytometry data.
Histology And Cytology Global Market Report 2024
Histology and cytology are interrelated branches of biology and medicine that focus on the microscopic study of tissues and cells, respectively. Histology examines tissue samples under a microscope to identify abnormalities in tissue architecture and cellular organization, aiding in diagnosing conditions such as cancer, inflammatory diseases, and infections.
Hematology Market By Size, Share and Forecast 2029F
Forecast Period 2025-2029 Market Size (2023) USD 16.34 Billion Market Size (2029) USD 22.20 Billion CAGR (2024-2029) 5.20% Fastest Growing Segment Coagulation Reagents Largest Market North America Market Overview Global Hematology Market was valued at USD 16.34 billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.20% through 2029.
Dotmatics Acquires EasyPanel to Expand Flow Cytometry Capabilities
Summary: Dotmatics has acquired EasyPanel, enhancing its flow cytometry solutions and expanding its scientific software portfolio to offer a comprehensive scientific intelligence platform for multimodal R&D. Takeaways: Enhanced Flow Cytometry Capabilities: The acquisition of EasyPanel, known for its intelligent and automated flow cytometry panel design software, complements Dotmatics’ existing solutions such as OMIQ and FCS Express, facilitating improved experimental outcomes.
Sepsis Diagnostics Market is Expected to Grow at a CAGR of 9.9% from 2024 to 2031; As Revealed In New Report
The global sepsis diagnostics market is estimated to be valued at US$ 841.4 million in 2023 and is expected to exhibit a CAGR of 9.9% during the forecast period (2023-2030).
Unleashing the Power of Immunity: Immuno Oncology Assays Market Innovations, Biomarkers, Clinical Applications, Therapeutic Insights, and Future Strategies
The global immuno-oncology assays market was valued at US$ 3,718.5 Mn in 2021 and is forecast to reach a value of US$ 7,594.6 Mn by 2028 at a CAGR of 10.7% between 2022 and 2028. Coherent Market Insights has released a new research report on the Global "Immuno Oncology Assays Market" for the year 2024, focusing on Size, Growth, Trends, and Dynamics, with forecasts up to 2031.
Cellular Health Screening Test Market Explore Future Growth With Top Key Players
The global cellular health screening test Market size is expected to reach US$ 6.61 billion by 2030, from US$ 2.90 billion in 2023, at a CAGR of 12.5% during the forecast period. Coherent Market Insights has released a new research report on the Global "Cellular Health Screening Test Market" for the year 2024, focusing on Size, Growth, Trends, and Dynamics, with forecasts up to 2031.
Immuno Oncology Assays Market Expected to Expand at a Steady 2024-2031
The Latest Report, titled "Immuno Oncology Assays Market" Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the global market.
Unraveling the Future: Immuno-Oncology Assays Market will generate new growth opportunities 2024-2031
Immuno-Oncology Assays Market The Latest Research Report on the Immuno-Oncology Assays Market 2024 to 2031 delivers precise economic forecasts, global and country-level predictions, and comprehensive analyses. It offers a detailed perspective on the competitive landscape and conducts an in-depth supply chain analysis to aid businesses in identifying significant shifts in industry practices.
The Evolution and Complications of Long-Term Mechanical Circulatory Support Devices
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Cellular Health Screening Test Market 2024 Trends, Growth Demand, Business Opportunities and Forecast To 2031
Cellular health screening tests analyze various biomarkers in cells to determine an individual's cellular health. These tests can provide insights into nutrition, aging, toxicity, and other health factors. They are useful for assessing risks of chronic diseases and developing personalized nutrition and wellness plans. Market Dynamics: Rising prevalence of chronic diseases such as cancer, heart disease, and diabetes is driving demand for cellular health screening tests.
Cellular Health Screening Test Market Growth in Future Scope 2024-2031
Global "Cellular Health Screening Test Market" 2024 Research Report presents a professional and complete analysis of the Cellular Health Screening Test Market in the current situation. This report includes development plans and policies along with Cellular Health Screening Test industrial processes and price structures.
Novel EGFR+ CD3+ Cell Mimics For Validating CAR-T Cell Enumeration By Flow Cytometry
A quality control lab such that uses in-house transduced CAR T-cells for validating flow cytometry panels and often as controls for each assay sought help for their challenges with significant lot-to-lot variability. The company, Fred Hutch Cellular Processing Facility QC lab (CPF QC), also struggled with unknown long-term stability of these human control cells limit standardization, reproducibility and comparability of the assay over time.
Novel EGFR+ CD3+ Cell Mimics For Validating CAR-T Cell Enumeration By Flow Cytometry
A quality control lab such that uses in-house transduced CAR T-cells for validating flow cytometry panels and often as controls for each assay sought help for their challenges with significant lot-to-lot variability. The company, Fred Hutch Cellular Processing Facility QC lab (CPF QC), also struggled with unknown long-term stability of these human control cells limit standardization, reproducibility and comparability of the assay over time.
Global Bioprocess Technology Market Overview - Market Growth Analysis And Key Drivers
Free Press Release DB | Press Release Date : Nov 8, 2023 Download The global bioprocess technology market size is expected to grow from $18.70 billion in 2022 to $21.90 billion in 2023 at a compound annual growth rate (CAGR) of 17.1 %.
Incidence, microbiological and immunological characteristics of ventilator-associated pneumonia assessed by bronchoalveolar lavage and endotracheal aspirate in a prospective cohort of COVID-19 patients: CoV-AP study | Critical Care | Full Text
Of the 95 patients enrolled, 5 were excluded due to consent withdrawal, and 11 further excluded for principal analyses due to incomplete collection of ETA or BAL at sVAP. Of the retained 79 patients, 49 (62%) had at least 1 episode of sVAP with concomitant ETA and BAL collection. Study flow chart is represented in Fig. 1, patients’ enrolment by month in Additional file 1: Fig. S1.
Light-inducible T cell engagers trigger, tune, and shape the activation of primary T cells | Proceedings of the National Academy of Sciences
Light-inducible T cell engagers trigger, tune, and shape the activation of primary T cells Morgane Jaeger, Amandine Anastasio, Léa Chamy, +11 , Sophie Brustlein, Renaud Vincentelli https://orcid.org/0000-0001-9667-0196, Fabien Durbesson https://orcid.org/0000-0001-7972-2054, Julien Gigan, Morgane Thépaut, Rémy Char, Maud Boussand, Mathias Lechelon https://orcid.org/0000-0002-7519-4028, Rafael J.
Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon
TO THE EDITOR: Targeted agent-based therapies such as covalent Bruton tyrosine kinase inhibitors (cBTKis) and venetoclax (VEN) plus anti-CD20 monoclonal antibodies have achieved superior outcomes over chemoimmunotherapy among patients with CLL with a range of fitness and comorbidity levels, in the first-line and relapsed/refractory (RR) settings.1-7 However, data to inform the optimal sequencing of targeted agents remain limited.8-10 Continuous VEN monotherapy has demonstrated efficacy in a...
New Method for Noninvasive Detection of Circulating Tumor Cells in Blood
Metastasis occurs when cancer cells acquire the ability to spread and form new tumors in different places in the body, usually by traveling within blood or lymph vessels. Since metastasis is a hallmark of advanced cancer and severely complicates treatment, its early diagnosis is essential. One way to do this is by looking for circulating tumor cells (CTCs) in blood samples.
Sepsis Diagnostics Market Report: Analysis of Effective Business Strategies 2023 To 2030 | BioMérieux SA, Thermo Fisher Scientific, Abbott Laboratories
Global Sepsis Diagnostics Market Growing Demand and Growth Opportunity 2023-2030: The global sepsis diagnostics market is estimated to be valued at US$ 702.2 Mn in 2022, and is expected to exhibit a CAGR of 9.6% over the forecast period (2023-2030). The latest report published by Coherent Market Insights highlights the growth prospects of Sepsis Diagnostics Market from 2023 to 2030. In-Depth Research on Industry Size, Share, Business Analysis, Growth Factors, and Regional Forecast..
Immuno-Oncology Assays Market Size and Share to See Modest Growth Through 2030 | Charles River, Roche, llumina, and Agilent Technologies, Inc.
The most recent report published by Coherent Market Insights indicates that the Immuno-Oncology Assays Market is likely to accelerate significantly in the next few years. The report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources.
Randox Enters Flow Cytometry Space with Acquisition
Randox has completed its acquisition of Cellix Limited, a Dublin-based company that develops microfluidic tools and impedance flow cytometers for cell analysis. The acquisition expands Randox’s technical capabilities into the benchtop flow cytometry space, which the company says aligns with its commitment to personalized medicine and improved preventative healthcare.
Optimized nucleus isolation protocol from frozen mouse tissues for single nucleus RNA sequencing application
1 Introduction To better understand the complexity of organs, many researchers have focused their studies on the characterization of the transcriptome of the cells that make up tissues of the studied organs. Nowadays, this characterization frequently relies on a technique called single cell RNA sequencing (scRNA-seq).
New Test Finds Intact Sperm in Infertile Men
In a recent study, researchers created a diagnostic test to identify functional intact sperm in infertile men that could change the treatment of male infertility and assisted reproductive technology. “Male infertility is a recognized issue and deserves scientific and clinical attention,” says Andrei Drabovich, an assistant professor of laboratory medicine and pathology at the University of Alberta and corresponding author of the Molecular & Cellular Proteomics study.
INTEGRATION OF T‐CELL CLONALITY SCREENING USING TRBC‐1 IN LYMPHOMA SUSPECT SAMPLES BY FLOW CYTOMETRY
Background: The diagnosis of T-cell non-Hodgkin lymphomas (NHL) is challenging. Many cases of T-NHL have normal immunophenotypes, and currently available T-cell clonality assays have limitations, including suboptimal sensitivity. The development of a monoclonal antibody (mAb) specific for T-cell receptor β constant region 1 (TRBC1) provides an alternative to discriminate clonal T cells.
Bioprocess Technology Market Industry Size, Trends And Forecast To 2032
Free Press Release DB | Press Release Date : Jun 2, 2023 Download The global bioprocess technology market size is expected to grow from $18.70 billion in 2022 to $21.90 billion in 2023 at a compound annual growth rate (CAGR) of 17.1%. The Business Research Company’s Bioprocess Technology Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies.
(PDF) Pluronic-F-127-Passivated SnO2 Nanoparticles Derived by Using Polygonum cuspidatum Root Extract: Synthesis, Characterization, and Anticancer Properties
Nanotechnology has emerged as the most popular research topic with revolutionary applications across all scientific disciplines. Tin oxide (SnO2) has been gaining considerable attention lately owing to its intriguing features, which can be enhanced by its synthesis in the nanoscale range. The establishment of a cost-efficient and ecologically friendly procedure for its production is the result of growing concerns about human well-being.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Flow
Contact Flow, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack